The authors showed that SIRT1 has effects on breast cancer cell growth through promoting the activity of oncogenic PI3K/Akt signaling pathway in vitro, and that SIRT1 is positively correlated with the expression of P-Akt in vivo [56]. Here, AKT1 is linked to breast cancer.